In this guest editorial, Dr. Anurag Singh discusses gastroenteritis diagnosis and how syndromic testing is establishing its role in the future of infectious disease management
Three interrelated Body of Knowledge papers outline roles and required skills for bioinformaticians with respect to molecular diagnostics, clinical bioinformatics, clinical laboratory regulation and data security
Over 200 exhibitors, AI-powered breakthroughs, and strategic forums set to transform regional healthcare
How cross-disciplinary collaboration and earlier recognition can transform outcomes for patients with Crohn’s disease and ulcerative colitis
Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds
Vote for the product that has made the most difference to your lab for the chance to win a $100 Amazon Gift Card (or equivalent currency)
Discover how prioritizing reproducibility and method validation can empower researchers to unlock the full potential of metabolomics in advancing biomarker discovery and drug development
The IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer’s disease and therapeutic drug monitoring
Due to its precise analytical performance, the HLC-723 GR01 enhances diagnostic confidence, supporting both high throughput and improved diabetes care
Licensing with a global enzyme provider for two Optimer reagents in research and diagnostics
New solutions from Siemens Healthineers address labs’ environmental and efficiency goals
The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine
Accuracy in ESR1 mutation testing means the difference between treatment and resistance — now a new ESR1 control kit ensures reliable results
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
For the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD)
Discover how thyroid stimulating immunoglobulin (TSI) testing enhances differentiation of Graves’ disease from other hyperthyroid conditions — enabling precise diagnoses and better patient care
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
New clinical insights reveal how this protein helps diagnose, monitor, and predict flare-ups in rheumatic diseases
As part of LabWeek, Dr. Umama Shahid shares her research on riboswitches and their potential to combat antimicrobial resistance
